Optimization of Unnicked<i>β</i>2-Glycoprotein I and High Avidity Anti-<i>β</i>2-Glycoprotein I Antibodies IsolationAndrej Artenjak, Saša Čučnik, Adrijana Leonardi et al.|Journal of Immunology Research|2014Cited by 8
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory DomainsMedha Barbhaiya, Thomas Dörner, María Laura Bertolaccini et al.|Current Rheumatology Reports|2025Cited by 0